Manorama Industries shareholders approve FY26 results and 40% dividend at AGM
- Shareholders approved FY26 financial statements and a final dividend of ₹0.80 per share (40%)
- Revenue grew 76.1% YoY to ₹13,577 million; PAT doubled to ₹2,332 million
- Net debt-to-equity ratio improved significantly to 0.38 from 0.83
- All five ordinary resolutions passed with overwhelming majority support

*this image is generated using AI for illustrative purposes only.
Manorama Industries shareholders approved the company’s financial statements for FY26 and declared a final dividend of 40% per equity share during its 21st Annual General Meeting on September 21, 2026. The meeting, conducted via video conference, also saw the reappointment of Whole-Time Director Gautam Kumar Pal.
The Board presented consolidated standalone results showing significant growth in top-line and bottom-line metrics for the fiscal year ended March 31, 2026. Management highlighted robust demand across food and cosmetics sectors as key drivers for the performance. The meeting commenced at 3:00 pm and concluded at 3:48 pm, with 54 members attending virtually.
Financial Performance Highlights
The company reported strong financial outcomes for FY26, reflecting expanded operational leverage and increased contribution from value-added specialty fats. Key standalone metrics disclosed during the proceedings are outlined below.
| Metric | FY26 | FY25 | Change |
|---|---|---|---|
| Revenue | ₹13,577 million | ₹7,708 million | +76.1% |
| EBITDA | ₹3,677 million | ₹1,911 million | +92.4% |
| PAT | ₹2,332 million | ₹1,121 million | +108.0% |
| EBITDA Margin | 27.1% | 24.8% | +230 bps |
Return on Equity (ROE) improved to 40.3% in FY26 from 28.1% in FY25. Similarly, Return on Capital Employed (ROCE) rose to 33.6% from 19.8%. The net debt-to-equity ratio declined significantly to 0.38 from 0.83, indicating strengthened balance sheet health following a successful Qualified Institutional Placement (QIP).
What the Numbers Show
The divergence between revenue growth (76.1%) and EBITDA growth (92.4%) underscores substantial operating leverage achieved by Manorama Industries in FY26. This expansion in margins coincided with a reduction in working capital days from 151 in FY25 to 125 in FY26, suggesting improved efficiency in cash conversion cycles alongside higher volume throughput.
Governance and Resolutions
Shareholders approved several ordinary resolutions during the AGM. Voting results submitted to exchanges confirm that all resolutions were passed with requisite majority. Key outcomes include:
- Adoption of audited standalone and consolidated financial statements for FY26 (Passed with 100% votes in favour).
- Reappointment of Mr. Gautam Kumar Pal as Whole-Time Director upon retirement by rotation (Passed with 99.92% votes in favour).
- Declaration of final dividend at ₹0.80 per equity share of face value ₹2 each (Passed with 99.99% votes in favour).
- Ratification of remuneration for Cost Auditors M/s. S N & Co (Passed with 100% votes in favour).
- Approval of material related-party transactions (Passed with 99.99% votes in favour among non-related parties).
All directors attended the meeting, including Chairman and Managing Director Ashish Ramesh Saraf. Statutory auditors M/s. Singhi & Co., secretarial auditors M/s. B.R. Agarwal & Associates, and internal auditor CLA Indus Value Consulting were present. The voting process was scrutinized by M/s. Mehta & Mehta, Company Secretaries.
Strategic Outlook
Management noted that Q1FY27 revenue grew 39.5% year-on-year, crossing the ₹400 crore quarterly milestone for the first time. Capacity expansions include a 30% increase in Solvent Fractionation Plant-II to 32,500 TPA. The company continues to focus on global expansion with a presence in over 39 countries and strategic investments in Burkina Faso for backward integration.
Historical Stock Returns for Manorama Industries
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -5.99% | -12.07% | -6.24% | +29.25% | +16.58% | +775.76% |
How will the 30% capacity expansion at Solvent Fractionation Plant-II impact Manorama Industries' ability to sustain its recent margin expansion in FY27?
What specific regulatory or geopolitical risks might the strategic backward integration investments in Burkina Faso pose to future supply chain stability?
Given the significant drop in net debt-to-equity ratio post-QIP, how does management plan to allocate the strengthened balance sheet capacity for further global expansion or M&A activities?


































